Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00999206
Registration number
NCT00999206
Ethics application status
Date submitted
20/10/2009
Date registered
21/10/2009
Date last updated
26/08/2011
Titles & IDs
Public title
Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine
Query!
Scientific title
Randomized, Double-Blind Study to Assess Safety, Immunogenicity, and Lot Consistency of Solvay's Cell-Derived Influenza Vaccine and Its Non-Inferiority Compared to Influvac®.
Query!
Secondary ID [1]
0
0
S203.3.013
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Influenza
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Other interventions - Influenza Vaccine
Other interventions - Influenza Vaccine
Other interventions - Influenza Vaccine
Other interventions - Influenza Vaccine
Experimental: 1 -
Experimental: 2 -
Experimental: 3 -
Active Comparator: 4 -
Other interventions: Influenza Vaccine
surface antigen, inactivated, prepared in cell cultures
Other interventions: Influenza Vaccine
surface antigen, inactivated, prepared in egg (influvac ®)
Other interventions: Influenza Vaccine
surface antigen, inactivated, prepared in cell cultures
Other interventions: Influenza Vaccine
surface antigen, inactivated, prepared in cell cultures
Query!
Intervention code [1]
0
0
Other interventions
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Anti-HA antibody titers and derived parameters seroprotection, seroconversion and fold increase
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
3 weeks
Query!
Eligibility
Key inclusion criteria
Inclusion Criteria
1. Female or male subjects >= 18 years of age (adults >= 18 to < =60 years of age or
elderly >= 61 years of age).
2. Willing and able to give informed consent before any protocol procedures are
performed.
3. Able to adhere to visit schedules and all protocol required study procedures.
4. Being in good health as determined by medical history, physical examination and
clinical judgment of the investigator (subjects may have underlying illnesses such as
hypertension, diabetes, ischemic heart disease or hypothyroidism, as long as the
disease is well controlled. If on medication for a condition, the medication dose must
have been stable for at least 3 months preceding study vaccination).
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Exclusion Criteria
1. Influenza vaccination or laboratory confirmed influenza infection within six months
preceding the date of study vaccination or planning an influenza vaccination during
the three weeks after study vaccination (i.e. between study Day 1 and study Day 22).
2. Presence of any significant condition that may prohibit inclusion as determined by the
Investigator.
3. A serious adverse reaction after a previous (influenza) vaccination.
4. A history of Guillain-Barré syndrome.
5. Known to be allergic to constituents of the study vaccines.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/01/2010
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/08/2010
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
3138
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment hospital [1]
0
0
Site Reference ID/Investigator# 44652 - Adelaide
Query!
Recruitment hospital [2]
0
0
Site Reference ID/Investigator# 44662 - Auchenflower
Query!
Recruitment hospital [3]
0
0
Site Reference ID/Investigator# 44651 - Blacktown
Query!
Recruitment hospital [4]
0
0
Site Reference ID/Investigator# 44659 - Blacktown
Query!
Recruitment hospital [5]
0
0
Site Reference ID/Investigator# 44647 - Broadmeadow
Query!
Recruitment hospital [6]
0
0
Site Reference ID/Investigator# 44649 - Caboolture
Query!
Recruitment hospital [7]
0
0
Site Reference ID/Investigator# 44646 - Carina Heights
Query!
Recruitment hospital [8]
0
0
Site Reference ID/Investigator# 44650 - Herston
Query!
Recruitment hospital [9]
0
0
Site Reference ID/Investigator# 44663 - Hornsby
Query!
Recruitment hospital [10]
0
0
Site Reference ID/Investigator# 44645 - Kippa-Ring
Query!
Recruitment hospital [11]
0
0
Site Reference ID/Investigator# 44644 - Malvern East
Query!
Recruitment hospital [12]
0
0
Site Reference ID/Investigator# 44648 - Maroubra Junction
Query!
Recruitment hospital [13]
0
0
Site Reference ID/Investigator# 44643 - Sherwood
Query!
Recruitment postcode(s) [1]
0
0
5000 - Adelaide
Query!
Recruitment postcode(s) [2]
0
0
4066 - Auchenflower
Query!
Recruitment postcode(s) [3]
0
0
2148 - Blacktown
Query!
Recruitment postcode(s) [4]
0
0
2292 - Broadmeadow
Query!
Recruitment postcode(s) [5]
0
0
4510 - Caboolture
Query!
Recruitment postcode(s) [6]
0
0
4152 - Carina Heights
Query!
Recruitment postcode(s) [7]
0
0
4006 - Herston
Query!
Recruitment postcode(s) [8]
0
0
2077 - Hornsby
Query!
Recruitment postcode(s) [9]
0
0
4020 - Kippa-Ring
Query!
Recruitment postcode(s) [10]
0
0
3145 - Malvern East
Query!
Recruitment postcode(s) [11]
0
0
2035 - Maroubra Junction
Query!
Recruitment postcode(s) [12]
0
0
4075 - Sherwood
Query!
Recruitment outside Australia
Country [1]
0
0
New Zealand
Query!
State/province [1]
0
0
Christchurch
Query!
Country [2]
0
0
New Zealand
Query!
State/province [2]
0
0
Dunedin
Query!
Country [3]
0
0
New Zealand
Query!
State/province [3]
0
0
Grafton
Query!
Country [4]
0
0
New Zealand
Query!
State/province [4]
0
0
Rotorua
Query!
Country [5]
0
0
New Zealand
Query!
State/province [5]
0
0
Tauranga
Query!
Country [6]
0
0
New Zealand
Query!
State/province [6]
0
0
Wellington
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Abbott Biologicals
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Commercial sector/Industry
Query!
Name [1]
0
0
Quintiles, Inc.
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
A phase 3 study to obtain additional safety and immunogenicity data on Solvay's cell-derived
seasonal trivalent subunit influenza vaccine in adult and elderly subjects without
significant illnesses and to demonstrate consistency of the immunogenicity of the three lots
of the same vaccine, comparison of cell-derived vaccine to Solvay's egg-derived vaccine
including assessment of non-inferior immunogenicity
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00999206
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Hanka de Voogd, MD
Query!
Address
0
0
Abbott Healthcare Products B.V.
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00999206
Download to PDF